PRODUCTS
| Product Name | Strength | Image (not to scale) | Pack Size | NDC # | RLD / Brand Name | TE Rating | Therapeutic Category |
|---|---|---|---|---|---|---|---|
| Varenicline Tartrate Tablets | 0.5mg |
 |
53 |
70748-127-49 |
Chantix® |
AB |
Smoking Cessation Aids |
| Turqoz™ | 0.3mg/0.03mg |
 |
28 x 3 |
68180-895-13 |
Lo/Ovral-28® |
AB |
Oral Contraceptives |
| Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate for oral solution. | 1.6g per 6 ounces |
 |
177mL |
43386-700-83 |
Suprep® Bowel Prep Kit |
AA |
Osmotic Laxative |
| Sevelamer Hydrochloride Tablets | 800mg |
|
180 |
70748-173-26 |
Renagel® |
AB |
Phosphate binders |
| Rufinamide Tablets USP | 200mg |
|
120 |
68180-803-16 |
Banzel® |
AB |
Anticonvulsants |
| Pentazocine and Naloxone Tablets USP | 50mg/0.5mg |
|
100 |
43386-680-01 |
Talwin® NX |
AB |
Adjunct to Anesthesia Opioid Analgesic |
| Moxifloxacin Ophthalmic Solution USP | 0.5% |
|
3mL in a 5mL bottle |
68180-421-01 |
Moxeza® |
AT2 |
Anti-infective |
| Mirabegron Extended-Release Tablets | 25mg |
|
30 |
68180-151-06 |
Myrbetriq® |
– |
Beta-3 Adrenergic Agonist |
| Merzee® (norethindrone acetate and ethinyl estradiol and ferrous fumarate capsules) | 1 mg/20 mcg |
|
28 |
43386-371-32 |
Taytulla® |
AB |
Oral Contraceptives |
| Lurasidone Hydrochloride Tablets | 20mg |
|
30 |
68180-670-06 |
Latuda® |
AB |
Atypical antipsychotics |
| Ganirelix Acetate Injection | 250mcg/0.5mL |
|
(1) 250mcg single-dose pre-filled syringe |
70748-274-01 |
Ganirelix Acetate Injection |
AP |
Competitive gonadotropin-releasing hormone antagonist (GnRH antagonist) |
| Formoterol Fumarate Inhalation Solution | 20mcg/2mL |
|
30 UD Vials |
70748-261-30 |
Perforomist® |
AN |
Long-acting beta agonists (LABAs)/ Bronchodilator |
*All registered trademarks are the property of their respective owners. These products are intended for U.S. residents only.
